{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 54, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 960225, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 568480, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 77, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Ruhl", "age": 67, "title": "Chief Technical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.76, "open": 7.54, "dayLow": 7.32, "dayHigh": 7.9899, "regularMarketPreviousClose": 7.76, "regularMarketOpen": 7.54, "regularMarketDayLow": 7.32, "regularMarketDayHigh": 7.9899, "payoutRatio": 0.0, "beta": 2.875, "forwardPE": -0.40712327, "volume": 13804, "regularMarketVolume": 13804, "averageVolume": 41458, "averageVolume10days": 80840, "averageDailyVolume10Day": 80840, "bid": 7.04, "ask": 7.95, "bidSize": 1, "askSize": 1, "marketCap": 47502368, "fiftyTwoWeekLow": 4.11, "fiftyTwoWeekHigh": 28.68, "fiftyDayAverage": 10.1353, "twoHundredDayAverage": 11.384595, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4375141, "profitMargins": 0.0, "floatShares": 774123, "sharesOutstanding": 6393320, "sharesShort": 13690, "sharesShortPriorMonth": 28277, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.09712, "heldPercentInstitutions": 0.80065, "shortRatio": 0.62, "shortPercentOfFloat": 0.0032, "impliedSharesOutstanding": 6393320, "bookValue": 6.415, "priceToBook": 1.1582229, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -34195000, "trailingEps": -12.17, "forwardEps": -18.25, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": 0.123, "52WeekChange": -0.5723741, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 7.43, "targetHighPrice": 150.0, "targetLowPrice": 61.0, "targetMeanPrice": 105.5, "targetMedianPrice": 105.5, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 16363000, "totalCashPerShare": 11.193, "ebitda": -35597000, "totalDebt": 0, "quickRatio": 1.907, "currentRatio": 2.059, "returnOnAssets": -0.67664003, "returnOnEquity": -1.37401, "freeCashflow": -18359000, "operatingCashflow": -29705000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Forte Biosciences, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -2.7052999, "fiftyDayAverageChangePercent": -0.2669186, "twoHundredDayAverageChange": -3.954595, "twoHundredDayAverageChangePercent": -0.3473637, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "regularMarketChange": -0.3300004, "regularMarketDayRange": "7.32 - 7.9899", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 41458, "fiftyTwoWeekLowChange": 3.3199997, "fiftyTwoWeekLowChangePercent": 0.8077858, "fiftyTwoWeekRange": "4.11 - 28.68", "fiftyTwoWeekHighChange": -21.25, "fiftyTwoWeekHighChangePercent": -0.74093443, "fiftyTwoWeekChangePercent": -57.23741, "dividendDate": 1592265600, "earningsTimestamp": 1743426000, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.17, "epsForward": -18.25, "epsCurrentYear": -3.67667, "priceEpsCurrentYear": -2.0208504, "longName": "Forte Biosciences, Inc.", "regularMarketChangePercent": -4.2525826, "regularMarketPrice": 7.43, "displayName": "Forte Biosciences", "trailingPegRatio": null}